
BioMark: 2025 Achievements & 2026 Vision
BioMark: 2025 Achievements & 2026 Vision

BioMark: 2025 Achievements & 2026 Vision
2025 Corporate Review
Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders
MedMira Reports First Quarter Results FY2026
Ventripoint Announces Non-Brokered Units Private Placement
Cheelcare Announces Second Quarter Fiscal 2026 Financial Results
Profound Medical Corp. Announces Closing of Private Placement
Pangenomic arranges $2-million private placement
PanGenomic Health Announces Non-Brokered Private Placement of up to $2,000,000
Conavi loses $20.5-million in fiscal 2025
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
Tempramed launches Vivi Cap Smart
Profound increases private placement to $6.45M (U.S.)
Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Across Core Platforms